5-Methoxy-6-methyl-3,4-dihydronaphthalen-1(2H)-one, 98%, 250mg

4-[(5-chloropyridin-2-yl)oxy]benzoic acid, 95%, 250mg

[(2H-1,3-benzodioxol-5-yl)methyl](butyl)amine, 95.0%, 10g

2-(2,5-DIMETHYL-1H-PYRROL-1-YL)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDINE, 95%, 1g

2-Hydroxyisobutyric acid, 95.0%, 100g

2-(Benzyloxy)-1-methylpyridin-1-ium trifluoromethanesulfonate, 97%, 1g

Rapamycin, 98%, 500mg

(3-Acryloxypropyl)methyldimethoxysilane inhibited with MEHQ, 95%, 50g

N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N6-((5-(dimethylamino)naphthalen-1-yl)sulfonyl)-L-lysine, 97%, 100mg

3-((2-Hydroxyethyl)(m-tolyl)amino)propanenitrile, 95+%, 100g

(3R,4R,5R)-3-FLUORO-4-HYDROXY-5-(HYDROXYMETHYL)-3-METHYLDIHYDROFURAN-2(3H)-ONE, 95.0%, 5g

4-Amino-2-methoxypyrimidine-5-carbaldehyde, 95.0%, 100mg

Accessories exchange block for reaction vessels, Gesch. for, 20 reaction vials 0.5 ml and 12 x 1.5 ml, 1 piece